Navigation Links
Promising new treatment for Alzheimer's suggested based on Hebrew University research
Date:7/20/2009

Research carried out at the Hebrew University of Jerusalem has resulted in a promising approach to help treat Alzheimer's disease in a significant proportion of the population that suffers from a particularly rapid development of this disease.

In the research at the Silberman Institute of Life Sciences of the Hebrew University, scientists solved a mystery as to why people who carried a mutated gene known as BChE-K were prone to more rapid development of Alzheimer's than those who had a normal version of the gene. This mutation appears in about 20 percent of the American and Israeli populations.

In theory, the carriers of the mutated gene should actually be more protected from the devastating effects of the disease, since the mutated protein (the enzyme that is the product of the gene) breaks down the neurotransmitter acetylcholine at a slower rate than in those who have the normal gene. The result is that the carriers maintain higher levels of this neurotransmitter, so they should in principle be protected from Alzheimer's disease, in which acetylcholine levels decrease.

Indeed, these carriers tend to develop the disease later than others, but when that happens, it progresses more rapidly and does not respond to medication. Therefore, the bottom line is that carriers of the mutated gene have a greater risk than others for disease progression. The reason for this anomalous situation has been a puzzle for a long time, but the studies by the Hebrew University scientists solved it by finding the explanation for this increased risk, thereby offering as well a possible new therapeutic solution.

At the Wolfson Center for Structural Biology at the Hebrew University, the researchers found that the mutation in the BChE-K gene damages the very end, or tail, of the resultant mutant enzyme protein. This tail is the part of BChE which is important for protection from the Alzheimer's disease plaques. It does this by interacting with the
'/>"/>

Contact: Rebecca Zeffert
rebeccaz@savion.huji.ac.il
972-258-81641
The Hebrew University of Jerusalem
Source:Eurekalert

Page: 1 2

Related biology news :

1. UIC researchers find promising new targets for antibiotics
2. New book defines promising young field of adult neurogenesis
3. Sirtris unveils promising, novel SIRT1 activators for treating diseases of aging
4. Cancer and arthritis therapy may be promising treatment for diabetes
5. Unique whey protein is promising supplement for strict PKU diet
6. Promising new drug targets identified for Huntingtons disease
7. Promising new nanotechnology for spinal cord injury
8. Biodesigns Rittmann offers promising perspectives on societys energy challenge
9. UIC researchers make promising finding in severe lung disease
10. New treatment approach promising for lymphoma patients in the developing world
11. Immunotherapy in high-risk pediatric sarcomas shows promising response

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)... The Lupus Research Institute (LRI) today named 12...ng $3.6 million, recognize innovative work across ...ted for their creativity, novelty, and potential t..., treat, and cure the complex disease of systemic ...blished lupus researchers across the nation and in...
(Date:11/24/2009)... Stents that keep weakened and flabby arteries fro... six months, those stents are no longer needed -- ...necessary. Previously, doctors had no choice but t...of Tel Aviv University,s Department of Biomedical ...er platform that carries drugs where they,re neede...
(Date:11/24/2009)..., NEW YORK (November 24, 2009) -- T...oday a report revealing that the last remaining po...gnificantly due to the rising tide of poaching and... will help inform Russian officials of what needs ... world,s biggest cat. , The report ...
Breaking Biology News(10 mins):Lupus Research Institute announces 2009 novel research grants 2Lupus Research Institute announces 2009 novel research grants 3A coating for life 2Report shows dramatic decline in Siberian tigers 2InfoLogix Achieves Motorola Enterprise Mobility Validation 54799 1InfoLogix Achieves Motorola Enterprise Mobility Validation 54799 2InfoLogix Achieves Motorola Enterprise Mobility Validation 54799 3Uninsured Patients to Receive Free Surgeries Procedures 54795 1Uninsured Patients to Receive Free Surgeries Procedures 54795 2Uninsured Patients to Receive Free Surgeries Procedures 54795 3Uninsured Patients to Receive Free Surgeries Procedures 54795 4Hospitals Reduce Heart Attack Deaths 54790 1Hospitals Reduce Heart Attack Deaths 54790 2Hospitals Reduce Heart Attack Deaths 54790 3
...University’s Massey Cancer Center studying the int...s have identified interferon gamma as one of the s...he findings may help researchers develop tailored ... fight a number of cancers. Immunotherapy involves...cing an antibody or lymphocytes, or immunization w...
...of Genes & Development, Dr. Karlene Cimprich a...ed the minimal DNA structure sufficient to activat...re very excited about these results," says Dr. Cim...late the nature of the checkpoint activating struc...ontrol, quantitative and probe checkpoint signalin...
...eserve grapes could help prevent allergies and boo...nifer Rohn in Chemistry & Industry, the magazi... the wine-making process to produce healthier wine...a and other conditions in some people. , Mass-mar...are usually treated with sulphur dioxide to preven...
Other Biology News:Mechanisms involved with tumor relapse identified 2Grape expectations for healthier wine 2
(Date:11/24/2009)... , CALGARY and BLENHEIM, Ontario, Nov. 24 /PRN...unced today it is acquiring the assets of Hyland S... Ontario. The addition of Hyland Seeds will furthe...as the company anticipates the introduction of Sm...icide Tolerant Trait Technology in corn in 2012. T...
(Date:11/24/2009)... , ST. LOUIS, Nov. 24 /PRNewswire-FirstCall...ll be presenting at the NASDAQ OMX conference on T...5 AM US/CST. Interested parties may listen via liv... http://inve s tor.sig m a a ldrich.com/ . ... file. ,, About Sigma-Aldrich: Sigma-Aldr...
(Date:11/24/2009)... , REYKJAVIK, Iceland, Novemb...nc. (Nasdaq: DCGN ) today announced the approval o...uptcy Court for the District of Delaware,(the "Ban...y petition for,relief under Chapter 11 of the Unit...t. , The orders issued by the Bankruptcy ...
(Date:11/24/2009)... , SAN MATEO, Calif., Nov. 24 /PRNewswire-...biopharmaceutical company focused on developing an... announced today that Anthony DiTonno, President a...t at the 21st Annual Piper Jaffray Health Care Con...York Palace Hotel in New York, New York. ,, Mr...
Breaking Biology Technology:Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 3deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3
...angamo BioSciences, Inc. (Nasdaq: SGMO ), the wo... finger DNA-binding proteins (ZFPs), announced tod...ges Explorations grant from the Bill & Melinda...vative global health research project conducted by...ses for In Vivo Treatment of HIV Infection." , ...
... Senesco Technologies, Inc. ("Senesco" or the "Co...al results for the three months ended March 31, 20...ed March 31, 2009 was $1,331,477, or $0.07 per sha...08 per share, for the three month period ended Mar...ily the result of a decrease in operating expenses...
...tion, Inc. (Nasdaq: MDVN ) today announced tha...anagement to discuss first quarter 2009 financial ...onday, May 11, 2009, at 4:30 p.m. Eastern Time. A...1, 2009 will be released after markets close on Ma...81-3376 from the U.S. or +1-719-325-4757 internati...
Other Biology Technology:Sangamo BioSciences Receives $100,000 Grand Challenges Explorations Grant for Innovative Global Health Research 2Sangamo BioSciences Receives $100,000 Grand Challenges Explorations Grant for Innovative Global Health Research 3Sangamo BioSciences Receives $100,000 Grand Challenges Explorations Grant for Innovative Global Health Research 4Senesco Technologies Reports Third Quarter Fiscal 2009 Financial Results 2Senesco Technologies Reports Third Quarter Fiscal 2009 Financial Results 3Senesco Technologies Reports Third Quarter Fiscal 2009 Financial Results 4Senesco Technologies Reports Third Quarter Fiscal 2009 Financial Results 5Senesco Technologies Reports Third Quarter Fiscal 2009 Financial Results 6Senesco Technologies Reports Third Quarter Fiscal 2009 Financial Results 7Medivation Announces First Quarter 2009 Financial Results Teleconference and Webcast on May 11, 2009 2
... a Voltage Clamp, as a Current Clamp or as a Condu...ch applications. Performance in any one mode is as... This amazing instrument is made possible by very ...nal Processing (DSP) integrated circuit chips. Unt...
7500 Series ICP-MS ChemStation Upgrade from Agilent Technologies
... microRNA expression profiling and built on the fl...ynthesis platform. These microarrays are available...Profiling Service. Probe Content The Soil Nemat...matode microRNAs (114 unique mature sequences). Th...
...to the maintenance of appropriate levels of short-...erse as those involved in cellular metabolism, hea... modulation of cell surface receptors and ion chan...gnalling factors. The ubiquitin-proteasome pathwa...
Biology Products: